Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma With Portal Vein Tumor Thrombus(PVTT)

Conditions: Stage IIIA Hepatocellular Carcinoma Interventions: Combination Product: Radiotherapy combined with TKI and Anti-PD-1 Antibody Sponsors: Fujian Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials